ENTITY
YiChang HEC ChangJiang Pharmaceutical

YiChang HEC ChangJiang Pharmaceutical (1558 HK)

137
Analysis
Health Care • China
YiChang HEC ChangJiang Pharmaceutical develops, manufactures, and sells pharmaceutical products, focusing on anti-viral, endocrine and metabolic, and cardiovascular diseases. Key products include Kewei (oseltamivir phosphate), Oumeining (telmisartan), and Ertongshu (benzbromarone). The company was founded in 2001 and is headquartered in Dongguan, China.
more
bullish•Tencent
•12 Aug 2019 11:10

HK Connect Ideas: Tencent Newsflow Before Earnings, Strong Southbound Flows (2019-08-09)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
603 Views
Share
bullish•ANTA Sports
•22 Jul 2019 11:39

HK Connect Ideas: Ten Weeks of Inflows, Sino Biopharm, Anta, Maoyan, H&H (2019-07-19)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
534 Views
Share
bullish•Liaoning Port
•17 Jun 2019 12:24

HK Connect Ideas: Five Weeks of Inflows, Dalian Port Outflows (2019-06-14)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
726 Views
Share
bullish•Geely Auto
•07 May 2019 13:19

HK Connect Ideas - April Snapshot (WH Group, Ping An, Geely)

This is a monthly version of our HK Connect Ideas weekly note, in which I highlight Hong Kong-listed companies leading the southbound flow on a...

Logo
968 Views
Share
bullish•Tencent
•23 Apr 2019 09:52

HK Connect Ideas: Longest Streak of Weekly Inflows YTD (2019-04-18)

In our weekly HK Connect Ideas series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed...

Logo
642 Views
Share
x